Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Johnson and Johnson
Novartis
Medtronic
McKesson
US Army
Merck
Teva
Federal Trade Commission
Chinese Patent Office

Generated: October 23, 2017

DrugPatentWatch Database Preview

DEXTROMETHORPHAN POLISTIREX Drug Profile

« Back to Dashboard

What is the patent landscape for Dextromethorphan Polistirex, and what generic Dextromethorphan Polistirex alternatives are available?

Dextromethorphan Polistirex is a drug marketed by Amneal Pharms Llc and Tris Pharma Inc and is included in two NDAs.

The generic ingredient in DEXTROMETHORPHAN POLISTIREX is dextromethorphan polistirex. There are twenty-two drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the dextromethorphan polistirex profile page.

Summary for Tradename: DEXTROMETHORPHAN POLISTIREX

US Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list33
Bulk Api Vendors: see list16
Clinical Trials: see list122
Patent Applications: see list5,793
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DEXTROMETHORPHAN POLISTIREX at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Llc
DEXTROMETHORPHAN POLISTIREX
dextromethorphan polistirex
SUSPENSION, EXTENDED RELEASE;ORAL203133-001Jul 28, 2017OTCNoNo► Subscribe► Subscribe► Subscribe
Tris Pharma Inc
DEXTROMETHORPHAN POLISTIREX
dextromethorphan polistirex
SUSPENSION, EXTENDED RELEASE;ORAL091135-001May 25, 2012OTCNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Medtronic
Chubb
Cerilliant
US Army
Merck
Citi
Federal Trade Commission
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot